Breaking News

Over a month ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
HEB

Hemispherx

$0.32

-0.0095 (-2.86%)

17:29
09/29/17
09/29
17:29
09/29/17
17:29
Syndicate
Breaking Syndicate news story on Hemispherx »

Hemispherx files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Over a quarter ago
HEB

Hemispherx

$0.41

0.0327 (8.74%)

08:36
08/14/17
08/14
08:36
08/14/17
08:36
Hot Stocks
Hemispherx commences human safety study of Ampligen plus FluMist »

Hemispherx Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Aug

HEB

Hemispherx

$0.39

-0.01 (-2.50%)

06:24
08/08/17
08/08
06:24
08/08/17
06:24
Hot Stocks
Hemispherx participated in meeting with advocates for ME/CFS in Canada »

Hemispherx Biopharma has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEB

Hemispherx

$0.52

0.007 (1.38%)

08:39
07/10/17
07/10
08:39
07/10/17
08:39
Hot Stocks
Hemispherx updates status of immuno-oncology program in pancreatic cancer »

Hemispherx announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEB

Hemispherx

$0.58

0.0086 (1.51%)

12:05
05/31/17
05/31
12:05
05/31/17
12:05
Hot Stocks
Hemispherx expands role of Joseph Horvath to Deputy Chief Medical Officer »

Hemispherx Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEB

Hemispherx

$0.57

-0.0005 (-0.09%)

11:41
05/31/17
05/31
11:41
05/31/17
11:41
Hot Stocks
Hemispherx announces promotion of Carol Smith to Chief Manufacturing Officer »

Hemispherx Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEB

Hemispherx

$0.68

0.003 (0.44%)

17:20
05/04/17
05/04
17:20
05/04/17
17:20
Syndicate
Breaking Syndicate news story on Hemispherx »

Hemispherx files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEB

Hemispherx

$0.50

-0.0008 (-0.16%)

08:42
03/06/17
03/06
08:42
03/06/17
08:42
Hot Stocks
Hemispherx meets Ampligen sales milestone in Q1 »

Hemispherx Biopharma…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ACRX

AcelRx

, AMRS

Amyris

$0.56

0.0133 (2.44%)

07:18
02/21/17
02/21
07:18
02/21/17
07:18
Conference/Events
Small Cap Nation to hold a symposium »

Family Office & Life…

ACRX

AcelRx

AMRS

Amyris

$0.56

0.0133 (2.44%)

CBMG

Cellular Biomedicine

$12.30

0.15 (1.23%)

DRNA

Dicerna

$2.91

-0.12 (-3.96%)

HEB

Hemispherx

$0.46

0.0007 (0.15%)

SRTS

Sensus Healthcare

$4.66

0.004 (0.09%)

VLY

Valley National

$12.41

-0.03 (-0.24%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 22

    Feb

  • 02

    Mar

  • 15

    May

HEB

Hemispherx

$0.64

-0.0424 (-6.19%)

08:41
02/02/17
02/02
08:41
02/02/17
08:41
Syndicate
Hemispherx announces $1M registered direct offering »

Hemispherx will issue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.